Section Arrow
OCUL.NASDAQ
- Ocular Therapeutix
Quotes are at least 15-min delayed:2026/02/28 14:53 EST
Regular Hours
Last
 8.94
-0.66 (-6.88%)
Day High 
9.58 
Prev. Close
9.6 
1-M High
11.13 
Volume 
5.52M 
Bid
8.93
Ask
9.38
Day Low
8.72 
Open
9.5 
1-M Low
6.2301 
Market Cap 
2.09B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 8.31 
20-SMA 8.7 
50-SMA 10.59 
52-W High 16.44 
52-W Low 5.785 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.42/-1.25
Enterprise Value
2.16B
Balance Sheet
Book Value Per Share
3.01
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
51.95M
Operating Revenue Per Share
0.27
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ENSCEnsysce Biosciences0.6232+0.22885+58.03%-- 
EDSAEdesa Biotech2.2+0.65+41.94%-- 
IBRXImmunityBio9.78+0.23+2.41%-- 
GOSSGossamer Bio0.4249+0.0229+5.70%-- 
QNCXQuince Therapeutics0.1257-0.0121-8.78%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.